首页> 外文期刊>Diabetes >Cellular Immune Responses Against Proinsulin No Evidence for Enhanced Reactivity in Individuals With IDDM
【24h】

Cellular Immune Responses Against Proinsulin No Evidence for Enhanced Reactivity in Individuals With IDDM

机译:对胰岛素原的细胞免疫反应没有证据表明IDDM患者具有增强的反应性

获取原文
获取原文并翻译 | 示例
       

摘要

Investigations of humans and nonobese diabetic mice suggest that proinsulin and/or fragment of the region spanning C-peptide and the B-chain of insulin (i.e., proinsulin peptide) may serve as key autoantigens in IDDM. Therefore, we analyzed cellular immune reac- Tivities against these molecules in people with or at Varying risks for the disease to clarify their role in the Pathogenesis of IDDM. In vitro peripheral blood Mononuclear cell (PBMC) responses against these anti- Gens, a control antigen (tetanus toxoid), and phyto- Hemaglutinin were determined in 60 individuals with Newly diagnosed IDDM (≤1 day from diagnosis) in 34 Islet cell cycoplasmic autoantibody- and/or insulin Autoantibody-negative first-degree relatives of the IDDM subjects, and in 28 autoantibody-negative control Subjects.
机译:对人类和非肥胖糖尿病小鼠的研究表明,胰岛素原和/或跨越胰岛素的C肽和B链的区域片段(即胰岛素原肽)可能是IDDM中的关键自身抗原。因此,我们分析了在患有或患有多种疾病的人群中针对这些分子的细胞免疫反应性,以阐明其在IDDM发病机理中的作用。在60例新诊断出IDDM(距诊断后≤1天)的个体中,在34个胰岛细胞胞浆自身抗体中确定了针对这些抗原的体外外周血单核细胞(PBMC)反应,对照抗原(破伤风类毒素)和植物血凝素-和/或IDDM受试者的胰岛素自身抗体阴性一级亲属,以及28名自身抗体阴性对照受试者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号